Patents/Assignees

Dana-farber Cancer Institute, Inc.

192 patents in portfolio

US11644466utility2023
Methods for Treating, Preventing and Predicting Risk of Developing Breast Cancer
0 cites
US11633415utility2023
Compounds and Methods Useful for Treating or Preventing Cancers
0 cites
US11634450utility2023
DOT1L Degraders and Uses Thereof
0 cites
US11590213utility2023
Targeted Expansion of Qa-1-peptide-specific Regulatory CD8 T Cells to Ameliorate Arthritis
0 cites
US11591403utility2023
IL-23R Antagonists to Reprogram Intratumoral T Regulatory Cells Into Effector Cells
0 cites
US11583586utility2023
Methods to Induce Targeted Protein Degradation Through Bifunctional Molecules
0 cites
US11584746utility2023
Inhibitors of EGFR and Methods of Use Thereof
0 cites
US11584788utility2023
Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Melanoma Using PD-L1 Isoforms
0 cites
US11578075utility2023
Degradation of Protein Kinases by Conjugation of Protein Kinase Inhibitors with E3 Ligase Ligand and Methods of Use
0 cites
US11572590utility2023
Methods for Evaluating Tumor Cell Spheroids Using 3D Microfluidic Cell Culture Device
0 cites
US11567082utility2023
Compositions, Assays, and Methods for Direct Modulation of Fatty Acid Metabolism
0 cites
US11542251utility2023
IRAK Degraders and Uses Thereof
0 cites

← PreviousPage 10 of 10